ADLINA EM 10/5 mg is a dual-action oral antidiabetic tablet that combines Empagliflozin (10 mg) and Linagliptin (5 mg). This fixed-dose combination offers a complementary mechanism of action to help patients with type 2 diabetes mellitus achieve better glycemic control—without increasing the risk of hypoglycemia or weight gain.